GSK and Google parent forge $715 million bioelectronic medicines firm

LONDON (Reuters) - GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.

GSK and Google parent forge $715 million bioelectronic medicines firm
Read More


Bagikan Berita Ini